Once the submission materials have been prepared in accordance with the Author Guidelines, manuscripts should be submitted online at https://mc.manuscriptcentral.com/ilabmed.

For help with submissions, please contact: ilabmed@tup.tsinghua.edu.cn

This journal does/does not charge submission fees. 

Article Preparation Support

Wiley Editing Services offers expert help with English Language Editing, as well as translation, manuscript formatting, figure illustration, figure formatting, and graphical abstract design – so you can submit your manuscript with confidence.

Also, check out our resources for Preparing Your Article for general guidance about writing and preparing your manuscript.

Free Format Submission

iLABMED now offers free format submission for a simplified and streamlined submission process.

Before you submit, you will need:

• Your manuscript: this should be an editable file including text, figures, and tables, or separate files—whichever you prefer. All required sections should be contained in your manuscript, including abstract, introduction, methods, results, and conclusions. Figures and tables should have legends. Figures should be uploaded in the highest resolution possible. References may be submitted in any style or format, as long as it is consistent throughout the manuscript. Supporting information should be submitted in separate files. If the manuscript, figures or tables are difficult for you to read, they will also be difficult for the editors and reviewers, and the editorial office will send it back to you for revision. Your manuscript may also be sent back to you for revision if the quality of English language is poor.
• An ORCID ID, freely available at https://orcid.org. (Why is this important? Your article, if accepted and published, will be attached to your ORCID profile. Institutions and funders are increasingly requiring authors to have ORCID IDs.)
• The title page of the manuscript, including:
  • Your co-author details, including affiliation and email address. (Why is this important? We need to keep all co-authors informed of the outcome of the peer review process.)
  • Statements relating to our ethics and integrity policies, which may include any of the following (Why are these important? We need to uphold rigorous ethical standards for the research we consider for publication):
    • data availability statement
    • funding statement
    • conflict of interest disclosure
    • ethics approval statement
    • patient consent statement
    • permission to reproduce material from other sources
    • clinical trial registration
    • Your co-author details, including affiliation and email address. (Why is this important? We need to keep all co-authors informed of the outcome of the peer review process.)
    • Statements relating to our ethics and integrity policies, which may include any of the following (Why are these important? We need to uphold rigorous ethical standards for the research we consider for publication)

Open Access

This journal is a:

Gold open access title. Article Publication Charge (APC) is waived for manuscripts submitted from 2023 to 2025. You can read more about APCs and whether you may be eligible for waivers or discounts, through your institution, funder, or a country waiver.

Preprint Policy

This journal accepts articles previously published on preprint servers. You are requested to update any pre-publication versions with a link to the final published article. You may also post the final published version of the article immediately after publication.

Registered Reports

See the Registered Reports Author Guidelines for full details.

Data Sharing and Data Availability 

This journal expects data sharing. Review Wiley’s Data Sharing policy where you will be able to see and select the data availability statement that is right for your submission. 

Data Citation

Please review Wiley's Data Citation policy.

Data Protection 

By submitting a manuscript to or reviewing for this publication, your name, email address, and affiliation, and other contact details the publication might require, will be used for the regular operations of the publication. Please review Wiley’s Data Protection Policy to learn more. 

Funding

You should list all funding sources in the Acknowledgments section. You are responsible for the accuracy of their funder designation. If in doubt, please check the Open Funder Registry for the correct nomenclature.

Acknowledgments

You should thank those people, companies or other groups that truly gave helps, but those helps were not enough made them to be listed as an author.

Authorship

All listed authors should have contributed to the manuscript substantially and have agreed to the final submitted version. Review editorial standards and scroll down for a description of authorship criteria.

ORCID

This journal requires ORCID. Please refer to Wiley's resources on ORCID.

Reproduction of Copyright Material

If excerpts from copyrighted works owned by third parties are included, credit must be shown in the contribution. It is your responsibility to also obtain written permission for reproduction from the copyright owners. For more information visit Wiley's Copyright Terms & Conditions FAQ.

Authors wishing to include figures, tables, or text passages that have already been published elsewhere (including in the authors’ own previous papers) are required to OBTAIN PERMISSION from the copyright owner(s) and to state clearly in the figure/table caption or other appropriate locations in the manuscript that such permission has been obtained. For example: Reproduced with permission from ref. xxx. Copyright American Chemical Society, 2008. Any content received without such evidence will be assumed to originate from the author(s). 

The corresponding author is responsible for obtaining written permission to reproduce the material "in print and other media" from the publisher of the original source, and for supplying Wiley with that permission upon submission.

Title Page

1. A brief informative title containing the major key words. The title should not contain abbreviations (see Wiley's best practice SEO tips);

2. The full names of the authors;

3. The authors’ institutional affiliations where the work was conducted, with a footnote for the author’s present address if different from where the work was conducted, and, if desired, twitter handles;

4. Acknowledgments. Acknowledgments should be any contributors who did not meet the requirements for authorship and any science writers or corporate employees who participated in the development of the manuscript.

Main Text File

Manuscripts can be uploaded either as a single document (containing the main text, tables and figures), or with figures and tables provided as separate files. Should your manuscript reach revision stage, figures and tables must be provided as separate files. The main manuscript file can be submitted in Microsoft Word (.doc or .docx) format.

• A short informative title containing the major key words. The title should not contain abbreviations;
• The full names of the authors with institutional affiliations where the work was conducted, with a footnote for the author’s present address if different from where the work was conducted;
• Acknowledgments;
• Abstract structured or unstructured;
• Up to 10 keywords;
• Practitioner Points (optional) Authors will need to provide no more than 3 ‘key points’, written with the practitioner in mind, that summarize the key messages of their paper to be published with their article;
• Main body: formatted as introduction, materials & methods, results, discussion, conclusion;
• References;
• Tables (each table complete with concise title and footnotes);
• Figure legends: Legends should be supplied as a complete list in the text. Figures should be uploaded as separate files (see below).

Graphical Abstracts

iLABMED publishes graphical abstracts for most articles, displayed online in graphical form with a brief abstract, in addition to the abstract above. The online table of contents will display a schematic figure to convey the core message of your paper, alongside a short abstract highlighting the major findings of the paper. Authors will be asked to submit a new and stand-alone image, or designate an image already included in the paper if your paper is accepted.

Your short abstract should consist of 2-3 sentences summarizing the essence of the paper. The image should fit within the dimensions of 50mm x 60mm, and be fully legible at this size.

Reference Style

This journal uses Vancouver reference style. Review your reference style guidelines prior to submission.

This journal uses Vancouver reference style reference style; as the journal offers free format submission, however, this is for information only and you do not need to format the references in your article. This will instead be taken care of by the typesetter.

Figures and Supporting Information

Figures, supporting information, and appendices should be supplied as separate files. You should review the basic figure requirements for manuscripts for peer review, as well as the more detailed post-acceptance figure requirements. View Wiley's FAQs on supporting information.

Peer Review

This journal operates under a single-anonymized peer review model. Except where otherwise stated, manuscripts are peer reviewed by at least two anonymous reviewers. Papers will only be sent to review if the Editor-in-Chief determines that the paper meets the appropriate quality and relevance requirements.

In-house submissions, i.e., papers authored by Editors or Editorial Board members of the title, will be sent to Editors unaffiliated with the author or institution and monitored carefully to ensure there is no peer review bias.

Wiley's policy on the confidentiality of the review process is available here.

Guidelines on Publishing and Research Ethics in Journal Articles

The journal requires that you include in the manuscript details IRB (Institutional Review Board) approvals, ethical treatment of human and animal research participants, and gathering of informed consent, as appropriate. You will be expected to declare all conflicts of interest, or none, on submission. Please review Wiley’s policies surrounding human studies, animal studies, clinical trial registration, biosecurity, and research reporting guidelines.

This journal follows the core practices of the Committee on Publication Ethics (COPE) and handles cases of research and publication misconduct accordingly (https://publicationethics.org/core-practices). 

This journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts. Read Wiley's Top 10 Publishing Ethics Tips for Authors and Wiley’s Publication Ethics Guidelines. 

Author Contributions

For all articles, the journal mandates the CRediT (Contribution Roles Taxonomy)—more information is available on our Author Services site.

The table below outlines general specifications of the different iLABMED article types.  

1. Original Article

Description: Scientific reports of new research findings or original primary research in laboratory medicine and related multidisciplinary research.

Word limit: 4,000 words maximum, excluding references, tables and figures.

Reference limit: No limit.

Abstract: The Abstract should be structured and up to 350 words. Please minimize the use of abbreviations and do not cite references in the abstract. Reports of randomized controlled trials should follow the CONSORT extension for abstracts. The abstract must include the following separate sections:

• Background: The context and purpose of the study;
• Methods: How the study was performed and statistical tests used;
• Results: The main findings;
• Conclusions: Brief summary and potential implications;
• Trial registration: If your article reports the results of a health care intervention on human participants, it must be registered in an appropriate registry and the registration number and date of registration should be stated in this section. If it was not registered prospectively (before enrolment of the first participant), you should include the words, ‘retrospectively registered’.

Keywords: 3 to 10 keywords representing the main content of the article.

Introduction: The Introduction section should explain the background to the study, its aims, a summary of the existing literature and why this study was necessary or its contribution to the field.

Figures/tables: 8 maximum.

Background: The Background section should explain the background to the study, its aims, a summary of the existing literature and why this study was necessary or its contribution to the field.

Methods: This section should include:

• the aim, design and setting of the study
• the characteristics of participants or description of materials
• a clear description of all processes, interventions and comparisons. Generic drug names should generally be used. When proprietary brands are used in research, include the brand names in parentheses
• the type of statistical analysis used, including a power calculation if appropriate

Results: This should include the findings of the study including, if appropriate, results of statistical analysis which must be included either in the text or as tables and figures.

Discussion: This section should discuss the implications of the findings in context of existing research and highlight limitations of the study.

Conclusions: This should state clearly the main conclusions and provide an explanation of the importance and relevance of the study reported.

List of abbreviations: If abbreviations are used in the text, they should be defined in the text at first use, and a list of abbreviations should be provided.

2. Review

Description: Reviews are summaries of recent insights in specific research areas within the scope of the journal. Key aims of Reviews are to provide systematic and substantial coverage of mature subjects, evaluations of progress in specified areas, and/or critical assessments of emerging technologies.

Word limit: 6,000 words maximum excluding references, tables and figures.

Reference limit: No limit.

Abstract: The Abstract should not exceed 250 words and should be unstructured (no use of sub-headers). Please minimize the use of abbreviations and do not cite references in the abstract.

Keywords: 3 to 10 keywords representing the main content of the article.

Background: The Background section should explain the background to the article, its aims, a summary of a search of the existing literature and the issue under discussion.

Main text: This should contain the body of the article, and may also be broken into subsections with short, informative headings.

Conclusions: This should state clearly the main conclusions and include an explanation of their relevance or importance to the field.

List of abbreviations: If abbreviations are used in the text they should be defined in the text at first use, and a list of abbreviations should be provided.

3. Commentary

Description: Commentaries can discuss a paper published in a specific issue and should set the problems addressed by the paper in the wider context of the field. Commentaries can also generally address unresolved and timely issues in laboratory medicine and related multidisciplinary research, and should provide ample evidence to support the authors' views. The topic should be of interest to the broad readership of iLABMED.

Word limit: Broad interest commentaries should be 1,500 words maximum; invited commentaries should be 1,000 words maximum.

Reference limit: 20 maximum.

First Look

After your paper is accepted, your files will be assessed by the editorial office to ensure they are ready for production. You may be contacted if any updates or final files are required. Otherwise, your paper will be sent to the production team.

Wiley Author Services

When an accepted article is received by Wiley’s production team, the corresponding author will receive an email asking them to login or register with Wiley Author Services. You will be asked to sign a publication license at this point as well as pay for any applicable APCs.

Copyright & Licensing

iLABMED is an Open Access journal: authors of accepted papers pay an Article Publication Charge (APC waived currently) and their papers are published under a Creative Commons license. This journal uses the CC-BY/CC-BY-NC/CC-BY-NC-ND Creative Commons License. Note that certain funders mandate a particular type of CC license be used.

Proofs

Authors will receive an e-mail notification with a link and instructions for accessing HTML page proofs online. Authors should also make sure that any renumbered tables, figures, or references match text citations and that figure legends correspond with text citations and actual figures. Proofs must be returned within 48 hours of receipt of the email.

Access and Sharing

Please review Wiley’s guidelines on sharing your research here. The submitted version of the manuscript, the accepted version, and the published version (Version of Record) can all be deposited on an institutional or other repository of the author's choice without embargo.

Article Promotion Support

Wiley Editing Services offers professional video, design, and writing services to create shareable video abstracts, infographics, conference posters, lay summaries, and research news stories for your research – so you can help your research get the attention it deserves.

Correction to Authorship

In accordance with Wiley’s Best Practice Guidelines on Research Integrity and Publishing Ethics and the Committee on Publication Ethics’ guidance, iLABMED will allow authors to correct authorship on a submitted, accepted, or published article if a valid reason exists to do so. All authors – including those to be added or removed – must agree to any proposed change. To request a change to the author list, please complete the Request for Changes to a Journal Article Author List Form and contact either the journal’s editorial or production office, depending on the status of the article. Authorship changes will not be considered without a fully completed Author Change form. Correcting the authorship is different from changing an author’s name; the relevant policy for that can be found in Wiley’s Best Practice Guidelines under “Author name changes after publication.”

iLABMED Editorial Office

Editorial Office Director: Yu Sun

Managing Editor: Shujiao Yang

Email: ilabmed@tup.tsinghua.edu.cn

Tel: +86-10-83470373

Address: Xueyan Building, Shuangqing Road, Haidian District, Beijing, 100084, China